MARGARET G MCGLYNN Insider Trading Transactions
Get free email notifications about insider trading for MARGARET G MCGLYNN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARGARET G MCGLYNN. MARGARET G MCGLYNN is Director in AIR PRODUCTS & CHEMICALS INC /DE/ ($APD) and Pres.U.S.Human Health in MERCK SHARP & DOHME CORP. ($MRK) and President, GV & ID in MERCK SHARP & DOHME CORP. ($MRK) and President, Merck Vaccines in MERCK SHARP & DOHME CORP. ($MRK) and President, MV & ID in MERCK SHARP & DOHME CORP. ($MRK) and Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in NOVAVAX INC ($NVAX) and Director in AMICUS THERAPEUTICS INC ($FOLD).
Latest Insider Trading Transactions of MARGARET G MCGLYNN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APD, FOLD, MRK, NVAX, VRTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | NVAX | NOVAVAX INC | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 700 | 0 | 700 | |
Jun 22 2021 | NVAX | NOVAVAX INC | MCGLYNN MARGARET G | Director | Option Exercise | A | 179.89 | 1,300 | 233,857 | 1,300 | |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 7.51 | 10,000 | 75,100 | 0 | |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 10.27 | 10,000 | 102,704 | 27,919 | 37.9 K to 27.9 K (-26.37 %) |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 7.51 | 10,000 | 75,100 | 37,919 | 27.9 K to 37.9 K (+35.82 %) |
May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 217.20 | 3,034 | 658,985 | 3,034 | |
May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 921 | 0 | 1,798 | 877 to 1.8 K (+105.02 %) |
Oct 01 2020 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 194 | 0 | 42,814 | |
Aug 26 2020 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Gift | G | 0.00 | 3,707 | 0 | 877 | 4.6 K to 877 (-80.87 %) |
Jul 02 2020 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 238 | 0 | 42,619 | |
Jun 08 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 12.81 | 18,574 | 237,933 | 18,574 | |
Jun 08 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 5,855 | 0 | 27,919 | 22.1 K to 27.9 K (+26.54 %) |
Jun 03 2020 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 286.27 | 2,264 | 648,115 | 2,264 | |
Jun 03 2020 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 699 | 0 | 4,584 | 3.9 K to 4.6 K (+17.99 %) |
Apr 20 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 2.81 | 10,000 | 28,100 | 0 | |
Apr 20 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 11.00 | 10,000 | 110,000 | 22,064 | 32.1 K to 22.1 K (-31.19 %) |
Apr 20 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 2.81 | 10,000 | 28,100 | 32,064 | 22.1 K to 32.1 K (+45.32 %) |
Apr 02 2020 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 237 | 0 | 42,381 | |
Jan 24 2020 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 630 | 0 | 42,145 | |
Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 3.32 | 20,000 | 66,400 | 0 | |
Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 10.00 | 20,000 | 200,000 | 22,064 | 42.1 K to 22.1 K (-47.55 %) |
Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 3.32 | 20,000 | 66,400 | 42,064 | 22.1 K to 42.1 K (+90.65 %) |
Jan 03 2020 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 204 | 0 | 41,514 | |
Nov 27 2019 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 3,973 | 0 | 41,311 | |
Nov 20 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Gift | G | 0.00 | 239 | 0 | 3,885 | 4.1 K to 3.9 K (-5.80 %) |
Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 72.14 | 20,000 | 1,442,800 | 0 | |
Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 190.00 | 20,000 | 3,800,000 | 4,124 | 24.1 K to 4.1 K (-82.90 %) |
Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 72.14 | 20,000 | 1,442,800 | 24,124 | 4.1 K to 24.1 K (+484.97 %) |
Oct 02 2019 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 199 | 0 | 37,246 | |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 81.54 | 10,000 | 815,400 | 0 | |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 81.54 | 10,000 | 815,400 | 0 | |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 185.00 | 10,000 | 1,850,000 | 4,124 | 14.1 K to 4.1 K (-70.80 %) |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 185.00 | 10,000 | 1,850,000 | 4,124 | 14.1 K to 4.1 K (-70.80 %) |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 81.54 | 10,000 | 815,400 | 14,124 | 4.1 K to 14.1 K (+242.48 %) |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 81.54 | 10,000 | 815,400 | 14,124 | 4.1 K to 14.1 K (+242.48 %) |
Jul 02 2019 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 195 | 0 | 37,046 | |
Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 12.00 | 19,473 | 233,676 | 19,473 | |
Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 6,250 | 0 | 22,064 | 15.8 K to 22.1 K (+39.52 %) |
Jun 04 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 1,801 | 0 | 3,989 | |
Jun 04 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 168.04 | 6,659 | 1,118,978 | 6,659 | |
Jun 04 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | D | 0.00 | 1,801 | 0 | 4,124 | 5.9 K to 4.1 K (-30.40 %) |
Apr 02 2019 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 217 | 0 | 36,852 | |
Jan 25 2019 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 952 | 0 | 36,634 | |
Jan 02 2019 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 256 | 0 | 35,682 | |
Oct 01 2018 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 236 | 0 | 35,426 | |
Jul 02 2018 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 254 | 0 | 35,190 | |
Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 2,188 | 0 | 2,188 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | D | 0.00 | 2,188 | 0 | 5,925 | 8.1 K to 5.9 K (-26.97 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 1,801 | 0 | 8,113 | 6.3 K to 8.1 K (+28.53 %) |
May 18 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 3.32 | 10,000 | 33,200 | 20,000 | |
May 18 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 16.00 | 10,000 | 160,000 | 15,814 | 25.8 K to 15.8 K (-38.74 %) |
May 18 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 3.32 | 10,000 | 33,200 | 25,814 | 15.8 K to 25.8 K (+63.24 %) |
Apr 03 2018 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 208 | 0 | 34,936 | |
Jan 29 2018 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 863 | 0 | 34,727 | |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 59.55 | 10,000 | 595,500 | 0 | |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 59.55 | 10,000 | 595,500 | 10,000 | |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 165.00 | 10,000 | 1,650,000 | 6,217 | 16.2 K to 6.2 K (-61.66 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 59.55 | 10,000 | 595,500 | 16,217 | 6.2 K to 16.2 K (+160.85 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 160.00 | 10,000 | 1,600,000 | 6,217 | 16.2 K to 6.2 K (-61.66 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 59.55 | 10,000 | 595,500 | 16,217 | 6.2 K to 16.2 K (+160.85 %) |
Jan 02 2018 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 200 | 0 | 33,864 | |
Oct 02 2017 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 215 | 0 | 33,664 | |
Jul 05 2017 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 223 | 0 | 33,449 | |
Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 5,814 | 0 | 5,814 | 0 to 5.8 K |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 2,188 | 0 | 6,217 | 4 K to 6.2 K (+54.31 %) |
Apr 04 2017 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 203 | 0 | 33,225 | |
Jan 27 2017 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 807 | 0 | 33,023 | |
Jan 04 2017 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 190 | 0 | 32,216 | |
Sep 30 2016 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 183 | 0 | 32,026 | |
Jul 05 2016 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 199 | 0 | 31,843 | |
Jul 05 2016 | APD | AIR PRODUCTS & CHE ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 199 | 0 | 31,843 | |
Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 93.51 | 7,073 | 661,396 | 7,073 | |
Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.01 | 2,941 | 29 | 4,029 | 1.1 K to 4 K (+270.31 %) |
Mar 31 2016 | APD | AIR PRODUCTS & ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 343 | 0 | 31,816 | |
Jan 29 2016 | APD | AIR PRODUCTS & ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 1,009 | 0 | 31,474 | |
Jan 05 2016 | APD | AIR PRODUCTS & ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 401 | 0 | 30,465 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 57.27 | 12,500 | 715,875 | 0 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 130.15 | 12,500 | 1,626,875 | 1,088 | 13.6 K to 1.1 K (-91.99 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 57.27 | 12,500 | 715,875 | 13,588 | 1.1 K to 13.6 K (+1,148.90 %) |
Nov 10 2015 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | P | 10.27 | 10,000 | 102,657 | 10,000 | 0 to 10 K |
Sep 30 2015 | APD | AIR PRODUCTS & ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 439 | 0 | 30,064 | |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 57.27 | 12,500 | 715,875 | 12,500 | |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 138.98 | 100 | 13,898 | 1,088 | 1.2 K to 1.1 K (-8.42 %) |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 138.22 | 2,700 | 373,194 | 1,188 | 3.9 K to 1.2 K (-69.44 %) |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 137.26 | 6,500 | 892,190 | 3,888 | 10.4 K to 3.9 K (-62.57 %) |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 136.49 | 3,200 | 436,768 | 10,388 | 13.6 K to 10.4 K (-23.55 %) |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 57.27 | 12,500 | 715,875 | 13,588 | 1.1 K to 13.6 K (+1,148.90 %) |
Jun 30 2015 | APD | AIR PRODUCTS & ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 388 | 0 | 29,625 | |
Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 53.85 | 7,500 | 403,875 | 0 | |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 57.27 | 5,000 | 286,350 | 25,000 | |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 127.54 | 20,000 | 2,550,800 | 20,000 | |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 127.53 | 9,020 | 1,150,321 | 1,088 | 10.1 K to 1.1 K (-89.24 %) |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 126.78 | 3,480 | 441,194 | 10,108 | 13.6 K to 10.1 K (-25.61 %) |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 53.85 | 7,500 | 403,875 | 13,588 | 6.1 K to 13.6 K (+123.19 %) |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 57.27 | 5,000 | 286,350 | 6,088 | 1.1 K to 6.1 K (+459.56 %) |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 53.85 | 12,500 | 673,125 | 7,500 | |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 119.78 | 400 | 47,912 | 1,088 | 1.5 K to 1.1 K (-26.88 %) |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 118.97 | 3,900 | 463,983 | 1,488 | 5.4 K to 1.5 K (-72.38 %) |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 118.32 | 6,000 | 709,920 | 5,388 | 11.4 K to 5.4 K (-52.69 %) |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 117.14 | 2,200 | 257,708 | 11,388 | 13.6 K to 11.4 K (-16.19 %) |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 53.85 | 12,500 | 673,125 | 13,588 | 1.1 K to 13.6 K (+1,148.90 %) |
Mar 31 2015 | APD | AIR PRODUCTS & ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 369 | 0 | 29,237 | |
Apr 27 2009 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Option Exercise | A | 0.00 | 7,650 | 0 | 7,650 | |
Apr 27 2009 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Option Exercise | A | 23.45 | 40,800 | 956,760 | 40,800 | |
Mar 06 2009 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Grant | A | 23.05 | 4,047 | 93,283 | 48,435 | 44.4 K to 48.4 K (+9.12 %) |
Mar 05 2009 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Option Exercise | A | 0.00 | 4,688 | 0 | 24,666 | |
Mar 05 2009 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Option Exercise | M | 0.00 | 4,688 | 0 | 0 | |
Mar 05 2009 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Option Exercise | M | 0.00 | 24,700 | 0 | 0 | |
Mar 05 2009 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Option Exercise | M | 0.00 | 4,687 | 0 | 0 | |
Mar 05 2009 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Payment of Exercise | F | 23.44 | 9,696 | 227,274 | 44,388 | 54.1 K to 44.4 K (-17.93 %) |
Mar 05 2009 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Buy | M | 0.00 | 24,700 | 0 | 54,084 | 29.4 K to 54.1 K (+84.06 %) |
Mar 05 2009 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Payment of Exercise | F | 23.44 | 1,690 | 39,614 | 29,384 | 31.1 K to 29.4 K (-5.44 %) |
Mar 05 2009 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Buy | M | 0.00 | 4,687 | 0 | 31,074 | 26.4 K to 31.1 K (+17.76 %) |
Mar 04 2008 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Option Exercise | A | 0.00 | 9,375 | 0 | 9,375 | |
Mar 04 2008 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, MV & ID | Option Exercise | A | 44.30 | 50,000 | 2,215,000 | 50,000 | |
Mar 03 2008 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, GV & ID | Grant | A | 45.44 | 5,905 | 268,323 | 26,139 | 20.2 K to 26.1 K (+29.18 %) |
Feb 27 2008 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, GV & ID | Option Exercise | M | 0.00 | 27,000 | 0 | 0 | |
Feb 27 2008 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, GV & ID | Option Exercise | M | 0.00 | 7,083 | 0 | 0 | |
Feb 27 2008 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, GV & ID | Option Exercise | A | 0.00 | 3,542 | 0 | 19,124 | |
Feb 27 2008 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, GV & ID | Payment of Exercise | F | 46.07 | 9,202 | 423,936 | 20,234 | 29.4 K to 20.2 K (-31.26 %) |
Feb 27 2008 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, GV & ID | Buy | M | 0.00 | 27,000 | 0 | 29,436 | 2.4 K to 29.4 K (+1,108.37 %) |
Feb 27 2008 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, GV & ID | Payment of Exercise | F | 46.07 | 1,105 | 50,907 | 2,436 | 3.5 K to 2.4 K (-31.21 %) |
Feb 27 2008 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, GV & ID | Buy | M | 0.00 | 3,541 | 0 | 3,541 | 0 to 3.5 K |
Nov 15 2007 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, GV & ID | Option Exercise | A | 0.00 | 4,400 | 0 | 4,400 | |
Mar 06 2007 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, Merck Va ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Mar 06 2007 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, Merck Va ... | Option Exercise | A | 0.00 | 9,375 | 0 | 9,375 | |
Mar 06 2007 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, Merck Va ... | Option Exercise | A | 44.19 | 50,000 | 2,209,500 | 50,000 | |
Mar 01 2007 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, Merck Va ... | Option Exercise | A | 0.00 | 7,500 | 0 | 15,124 | |
Mar 01 2007 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, Merck Va ... | Option Exercise | M | 0.00 | 7,500 | 0 | 0 | |
Mar 07 2006 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, Merck Va ... | Option Exercise | A | 0.00 | 24,700 | 0 | 24,700 | |
Mar 07 2006 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, Merck Va ... | Option Exercise | A | 0.00 | 9,375 | 0 | 9,375 | |
Mar 07 2006 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | President, Merck Va ... | Option Exercise | A | 35.09 | 50,000 | 1,754,500 | 50,000 | |
Nov 30 2005 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | Pres.U.S.Human Heal ... | Gift | G | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
Nov 30 2005 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | Pres.U.S.Human Heal ... | Gift | G | 0.00 | 7,000 | 0 | 0 | 7 K to 0 (-100.00 %) |
Mar 01 2005 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | Pres.U.S.Human Heal ... | Option Exercise | A | 0.00 | 27,000 | 0 | 27,000 | |
Mar 01 2005 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | Pres.U.S.Human Heal ... | Option Exercise | A | 0.00 | 7,083 | 0 | 7,083 | |
Mar 01 2005 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | Pres.U.S.Human Heal ... | Option Exercise | A | 31.84 | 42,500 | 1,353,200 | 42,500 | |
Mar 05 2004 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | Pres.U.S.Human Heal ... | Option Exercise | A | 0.00 | 6,702 | 0 | 6,702 | |
Mar 02 2004 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | Pres.U.S.Human Heal ... | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
Mar 02 2004 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | Pres.U.S.Human Heal ... | Option Exercise | A | 48.24 | 45,000 | 2,170,800 | 45,000 | |
Feb 04 2004 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | Pres.U.S.Human Heal ... | Buy | P | 48.00 | 2,500 | 120,000 | 7,000 | 4.5 K to 7 K (+55.56 %) |
Feb 04 2004 | MRK | MERCK SHARP & ... | MCGLYNN MARGARET G | Pres.U.S.Human Heal ... | Sell | I | 48.07 | 2,064 | 99,216 | 5,330 | 7.4 K to 5.3 K (-27.91 %) |
Page: 1